| Literature DB >> 28320723 |
Carmen M Martín-Navarro1, Atteneri López-Arencibia1,2, Ines Sifaoui1,3, María Reyes-Batlle1, Emilie Fouque2, Antonio Osuna4, Basilio Valladares1, José E Piñero1, Yann Héchard2, Sutherland K Maciver5, Jacob Lorenzo-Morales6.
Abstract
Free-living amoebae of the genus Acanthamoeba are the causal agents of a sight-threatening ulceration of the cornea called Acanthamoeba keratitis, as well as the rare but usually fatal disease granulomatous amoebic encephalitis. Although there are many therapeutic options for the treatment of Acanthamoeba infections, they are generally lengthy and/or have limited efficacy. For the best clinical outcome, treatments should target both the trophozoite and the cyst stages, as cysts are known to confer resistance to treatment. In this study, we document the activities of caffeine and maslinic acid against both the trophozoite and the cyst stages of three clinical strains of Acanthamoeba These drugs were chosen because they are reported to inhibit glycogen phosphorylase, which is required for encystation. Maslinic acid is also reported to be an inhibitor of extracellular proteases, which may be relevant since the protease activities of Acanthamoeba species are correlated with their pathogenicity. We also provide evidence for the first time that both drugs exert their anti-amoebal effects through programmed cell death.Entities:
Keywords: Acanthamoeba; PCD; caffeine, maslinic acid, programmed cell death
Mesh:
Substances:
Year: 2017 PMID: 28320723 PMCID: PMC5444160 DOI: 10.1128/AAC.02660-16
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191